A new ketamine-based antidepressant raises hope — and questions

The anesthetic drug’s long-term effects on people aren’t clear

depression drug

FAST RELIEF  A new drug based on the anesthetic ketamine relieves depression in hard-to-treat cases, but its long-term consequences are unknown.

Janssen Pharmaceuticals, Inc.

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content